Obagi Medical announced DermFx as a key partner for the Aesthetics Leadership with Obagi’s Hyaluronic Acid Program. DermFx will help generate real-world data to translate the clinical safety and efficacy demonstrated in FDA pivotal trials into everyday practice across multiple locations and structured evaluation programs that will highlight the value of ALOHA to DermFx.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WALD:
- Obagi Medical, Moxie collaborate for ALOHA program
- Obagi Medical, VIO Med Spa announce collaboration in ALOHA program
- Obagi Medical, Next Health collaborate for ALOHA program
- Obagi Medical, Alpha Aesthetic Partners collaborate for ALOHA program
- Obagi Medical, Platinum Dermatology Partners collaborate for ALOHA program